Robert Copeland is the founder of Accent Therapeutics. Accent Therapeutics has raised $140M in total funding. Latest round: Series A. Based in Cambridge, USA.
Robert Copeland is a co-founder of Accent Therapeutics, a biopharmaceutical company based in Cambridge, Massachusetts, developing epitranscriptomic RNA therapies for cancer. He served as President and Chief Scientific Officer from its founding in 2017 until 2024. He co-founded the company with Howard Y. Chang and Chuan He.
Full founder directory · Investor directory · Company funding database · Fundraising library